sábado, 20 de septiembre de 2025

FDA approves pembrolizumab and berahyaluronidase alfa-pmph for subcutaneous injection

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-and-berahyaluronidase-alfa-pmph-subcutaneous-injection

No hay comentarios:

Publicar un comentario